Media Matters要求美法院阻止聯邦貿委會就其涉串謀廣告抵制社交平台X的調查
《路透》報道,Media Matters要求法院阻止美國聯邦貿易委員會調查其是否與其他媒體監督團體串謀廣告抵制。
當局要求Media Matters提交其與其他團體的通訊記錄,以及某些團體策劃廣告抵制美國富豪馬斯克旗下社交平台X的文件。Media Matters稱沒有任何證據指控其串謀抵制行動,且當局的要求已限制其發表關於X和馬斯克的文章。
X於2023年向Media Matters提出訴訟,指對方在報道中誹謗公司,該報道稱主要品牌的廣告出現在X上宣傳極右翼內容的帖子旁。Media Matters否認指控,並於今年反告X,指其濫訴以懲罰該組織。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.